Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Lymphoma, Large B-Cell, Diffuse × zimberelimab × 90 days × Clear all

Sponsor

Conditions

Stomach Neoplasms 4 Carcinoma, Non-Small-Cell Lung 4 Uterine Cervical Neoplasms 3 Carcinoma, Renal Cell 3 Squamous Cell Carcinoma of Head and Neck 2 Recurrence 2 Pancreatic Neoplasms 2 Neoplasm Metastasis 2 Lung Neoplasms 2 Kidney Neoplasms 2 Adenocarcinoma Of Esophagus 2 Vulvar Neoplasms 1 Vaginal Neoplasms 1 Urothelial Bladder Carcinoma 1 Urinary Bladder Neoplasms 1 Triple Negative Breast Neoplasms 1 Solid Tumor 1 Ovarian Neoplasms 1 Neoplasms 1 Metastatic Urothelial Cancer 1 Glioblastoma 1 Esophageal Neoplasms 1 Erythrocytosis, Familial, 4 1 Cholangiocarcinoma 1 Carcinoma, Transitional Cell 1 Carcinoma, Neuroendocrine 1 Bile Duct Neoplasms 1 Advanced Solid Tumor 1

Interventions

Cyclophosphamide 38 Rituximab 35 Prednisone 22 Doxorubicin 21 fludarabine 15 Vincristine 15 Specimen Handling 14 Oxaliplatin 14 Magnetic Resonance Spectroscopy 14 Lenalidomide 14 Gemcitabine 14 polatuzumab vedotin 13 CT-P10 11 Etoposide 10 Biopsy 9 fludarabine phosphate 7 deltacortene 7 axicabtagene ciloleucel 7 Leukapheresis 7 Immunotherapy, Adoptive 7 venetoclax 6 prednylidene 6 glofitamab 6 pembrolizumab 5 obinutuzumab 5 ibrutinib 5 acalabrutinib 5 Prednisolone 5 tisagenlecleucel 4 pegfilgrastim 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡